Clarivate names Highly Cited Researchers
The annual list recognizes scientists whose published findings have broadly influenced their fields
This year 38 UW School of Medicine faculty members and scientists affiliated with UW Medicine have been named to the Clarivate Highly Cited Researchers™ list. The list was released today, Nov. 15.
Both quantitative and qualitative methods are used to identify individuals from across the globe who have demonstrated significant and broad influence in their chosen area of research.
The preliminary list of Highly Cited Researchers is drawn from the highly cited papers that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index over the past decade. The list also identifies the research institutions and regions where they are based.
The methodology that determines the influential researchers draws on analyses by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate.
The 2022 list of Clarivate Highly Cited UW School of Medicine and affiliated researchers includes, in alphabetical order:
David Baker, Biochemistry, Institute for Protein Design, computer design and engineering of proteins not found in nature
William Banks, Gerontology/Geriatrics and Puget Sound VA Health Care System, healthy aging and longevity
William Catterall, Pharmacology, ion channels
Riza Daza, Genome Sciences, high throughput sequencing and chromatin accessibility analysis to create libraries and cell atlases from a plurality of single cells.
E. Patchen Dellinger, Surgery, improving surgery safety standards and preventing surgical infections
Frank DiMaio, Biochemistry, Institute for Protein Design, protein structure prediction and modeling
Evan Eichler, Genome Sciences, human genome evolution, human genome variants and their role in disease
Janet Englund, Pediatrics and Seattle Children's, infectious diseases in youngster
Holly E. Erskine, Institute for Health Metrics and Evaluation, and Auckland Centre for Mental Health Research, Australia, epidemiology of neuropsychiatric conditions in children and teenagers
Michael Gale, Jr. Immunology, virus and host interactions
Sean M. Gibbons, Bioengineering, and Institute for Systems Biology, microbial ecology, evolution and ecosystem function in the mammalian gut.
Simon I. Hay, Institute for Health Metrics and Evaluation, use of big data and geospatial science in work on malaria and other diseases
Celestia Higano, Medicine/Oncology, Urology, and Fred Hutchinson Cancer Center, genital and urinary cancers
Neil P. King, Biochemistry, Institute for Protein Design, nanoparticle vaccine platforms and computer design of nanomaterials for targeted drug delivery
Cara Lewis, Psychiatry and Behavioral Sciences and Kaiser Permanente Health Research Institute, measurements in mental and social health
Gary H. Lyman, Medicine/Division of Medical Oncology, and Fred Hutchinson Cancer Center, cancer outcomes research
Philip Mease, Medicine/Rheumatology (also Swedish and Providence Hospitals), emerging therapies for rheumatic diseases
Ali Mokdad, Institute for Health Metrics and Evaluation, population health
Thomas Montine, Pathology (now at Stanford University), neurodegenerative diseases, including Alzheimer's and Parkinson's
Christopher J.L. Murray, Institute for Health Metrics and Evaluation, global burden of disease
Mohsen Naghavi, Institute for Health Metrics and Evaluation, causes of death around the world, including war, disasters, and terrorism.
Deborah Nickerson (deceased), Genome Sciences, human DNA sequencing for rare and common disorders
William Noble, Genome Sciences, machine learning to interpret complex biological data
Hans D. Ochs, Pediatrics and Seattle Children’s, immune diseases in youngsters
David Pigott, Health Metrics and Evaluation, spatial epidemiology of pathogens with outbreak potential
Ganesh Raghu, Medicine/Pulmonary, Critical Care and Sleep Medicine, interstitial lung diseases
Stanley Riddel, Medicine/Medical Oncology and Fred Hutch Cancer Center, engineering T cells to seek and destroy cancers.
Will Sheffler, Biochemistry, Institute for Protein Design, computationally designed protein platforms and multi-unit assemblies
Jay Shendure, Genome Sciences, Brotman Baty Institute for Precision Medicine, Allen Institute, developing and applying new technologies in genomics
David L. Smith, Institute for Health Metrics and Evaluation, computational epidemiology, disease ecology, mathematical modelling and policy analytics for global health
John Stamatoyannopoulos, Genome Sciences and Medicine (now at Altius Institute for Biomedical Sciences), regulatory regions of the genome
Alejandra Tortorici, Biochemistry and Institut Pasteur, Paris, structural studies of coronavirus spike protein during cell fusion and entry
Cole Trapnell, Genome Sciences, genes that govern stem cell maintenance, differentiation and cell fate decisions
Piper Meigs Treuting, Comparative Medicine, Laboratory Medicine and Pathology, and Seagen, Inc., veterinary pathology
David Veesler, Biochemistry, structure and function of infectivity machinery in coronaviruses, and of antibody interactions with these mechanisms
Alexandra “Lexi” Walls, Biochemistry (now at BioNTech SE, Cambridge, Mass.), structure and function of infectivity machinery in coronaviruses to assist vaccine design
Theo Vos, Institute for Health Metrics and Evaluation, global burden of disease studies relevant to policy decision making
Ning Zheng, Pharmacology, protein structure and function, protein interactions and intracellular signaling
For details about UW Medicine, please visit http://uwmedicine.org/about.